Pediatric Interventional Cardiology Market Report 2022: Growth, Demand Status, Key Players, Analysis 2027

IMARC Group has recently released a new research study titled "Pediatric Interventional Cardiology Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global pediatric interventional cardiology market reached a value of US$ 2.28 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 3.46 Billion by 2027, exhibiting a CAGR of 6.80% during 2022-2027.

Pediatric interventional cardiology refers to the treatment and diagnosis of congenital heart defects in children by utilizing cardiac catheterization. It involves placing a small, flexible and hollow catheter into the blood vessel and threading it through the vessel into the heart to carry out multiple tests. It provides various opportunities to surgeons for conducting minimally invasive surgeries (MIS) and measure aspects, such as blood pressure, oxygen levels in the blood, and flow of blood, to examine the structure of the heart and treat a wide range of congenital heart defects.

Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pediatric-interventional-cardiology-market/requestsample

Pediatric Interventional Cardiology Market Trends and Drivers:

At present, the increasing demand for pediatric interventional cardiology as an alternative to open heart surgeries represents one of the primary factors supporting the growth of the market. Besides this, the rising construction of hospitals, nursing homes, and clinics to provide quality healthcare facilities to patients is propelling the growth of the market.

In addition, the growing advancements made in medical science to improve the treatment and diagnosis of various life-threatening diseases are offering a favorable market outlook. Apart from this, the increasing adoption of minimally invasive (MI) surgical methods to reduce scarring and recovery duration and minimize hospital expenses is contributing to the growth of the market.

Additionally, the rising occurrence of various congenital cardiac complications in children, such as atrial septal defect (ASD), ventricular septal defect (VSD), and patent ductus arteriosus (PDA) due to genetic instabilities and adoption of unhealthy lifestyle habits during pregnancy is bolstering the growth of the market.

𝗖𝗵𝗲𝗰𝗸𝗼𝘂𝘁 𝗡𝗼𝘄: https://www.imarcgroup.com/checkout?id=5043&method=1

Global Pediatric Interventional Cardiology Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Biotronik SE & Co. KG, Boston Scientific Corporation, Cardinal Health Inc., Edwards Lifesciences Corporation, General Electric Company, Koninklijke Philips N.V., Lepu Medical Technology (Beijing) Co. Ltd., Medtronic plc, NuMED Inc., Siemens Healthineers AG, Terumo Corporation and W. L. Gore & Associates Inc.

The report has segmented the market on the basis of region, device type, procedure and end use.

Breakup by Device Type:
• Closure Devices
• Transcatheter Heart Valves
• Atherectomy Devices
• Catheters
• Balloons
• Stents
• Others

Breakup by Procedure:
• Catheter-Based Valve Implantation
• Congenital Heart Defect Correction
• Angioplasty
• Coronary Thrombectomy
• Others

Breakup by End Use:
• Clinical Testing Laboratories
• Hospitals
• Cardiac Centers
• Pediatric Clinics
• Research Institutions

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/pediatric-interventional-cardiology-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Browse Other Reports:

C-Arms Market 2022 : https://www.imarcgroup.com/c-arms-market

Macular Degeneration Treatment Market 2023 : https://www.imarcgroup.com/macular-degeneration-treatment-market

Hemoglobinopathies Market 2022 : https://www.imarcgroup.com/hemoglobinopathies-market

Veterinary Molecular Diagnostics Market 2022: https://www.imarcgroup.com/veterinary-molecular-diagnostics-market

Liquid Biopsy Market 2022 : https://www.imarcgroup.com/liquid-biopsy-market

Structural Heart Imaging Market 2023 : https://www.imarcgroup.com/structural-heart-imaging-market

Anti-venom Market 2022 : https://www.imarcgroup.com/anti-venom-market

Hospital Stretchers Market 2022 : https://www.imarcgroup.com/hospital-stretchers-market

IMARC Services Private Limited.
134 N 4th St.
Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.